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Deleterious Mutations in the Zinc-Finger 469 Gene
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Brittle cornea syndrome (BCS) is an autosomal-recessive disorder characterized by a thin cornea that tends to perforate, causing progres-
sive visual loss and blindness. Additional systemic symptoms such as joint hypermotility, hyperlaxity of the skin, and kyphoscoliosis
place BCS among the connective-tissue disorders. Previously, we assigned the disease gene to a 4.7 Mb interval on chromosome
16q24. In order to clone the BCS gene, we ﬁrst narrowed the disease locus to a 2.8 Mb interval and systematically sequenced genes
expressed in connective tissue in this chromosomal segment. We have identiﬁed two frameshift mutations in the Zinc-Finger 469
gene (ZNF469). In ﬁve unrelated patients of Tunisian Jewish ancestry, we found a 1 bp deletion at position 5943 (5943 delA), and in
an inbred Palestinian family we detected a single-nucleotide deletion at position 9527 (9527 delG). The function of ZNF469 is unknown.
However, a 30% homology to a number of collagens suggests that it could act as a transcription factor involved in the synthesis and/or
organization of collagen ﬁbers.Brittle cornea syndrome (BCS [MIM 229200]) is an autoso-
mal-recessive disorder characterized by a thin and fragile
cornea that tends to perforate spontaneously or as a result
of minor trauma to the eye. Keratoconus, keratoglobus,
and a blue sclera are common associated ﬁndings.1–6
Despite the use of protective measures, patients suffer
from progressive visual deterioration that often leads to
blindness.1–3,7,8 Systemic manifestations include joint hy-
permobility with occasional dislocations, hyperlaxity of
the skin, kyphoscoliosis, a progressive conductive-hearing
defect, dental abnormalities, and an increased incidence of
hernias.5,6,9–11 Electron microscopy studies performed on
skin biopsies from BCS patients showed 20- to 60-mi-
cron-wide ‘‘holes,’’ or ﬁber-free spaces, ﬁlled with amor-
phous material, distributed over its whole thickness,11
but the molecular basis of this disease remained unknown.
Since the original description by Stein et al.,1 more than
60 BCS patients have been reported. In Israel, BCS has been
described mainly among Jews of Tunisian origin. Interest-
ingly, all but one of the Tunisian Jewish BCS patients had
red hair. This is in contrast to patients from other ethnic
origins that show a normal distribution of hair color. Based
on this observation, Zlotogora et al.6 suggested linkage
disequilibrium between the BCS gene and a gene responsi-
ble for hair color in Tunisian Jews.
In a previous study, we assigned the BCS gene to a 4.7Mb
interval on chromosome 16q24, very close to the location
of the hair-color gene, MC1R12 [MIM 155555]. In this
report, we present evidence showing that BCS is caused
by mutations in the Zinc-Finger 469 gene (ZNF469) [GI:
113426575].
The study was approved by the institutional review
board at the Sheba Medical Center, Israel, and all partici-The Ampants granted informed consent. The ﬁve BCS patients of
Tunisian Jewish ancestry included in this study have
been previously reported.12 Recently, we have encountered
an additional highly inbred Palestinian family with six
affected members. The patients in this family manifested
typical disease features (Figure 1), but none of them had
red hair. Twenty milliliters of heparinized blood were
drawn from all family members, and DNA was extracted
via a commercial kit (Gentra System, Minneapolis, MN,
USA). In silico data mining of genomic clones within the
linkage interval at 16q24.1–24.3 identiﬁed two new poly-
morpic markers, which were annotated as D16S3436 and
D16S3437. We assumed that all the Tunisian Jewish
patients are descendents of a common founder and there-
fore are all homozygous for the same chromosomal
segment in the vicinity of the gene. Genotyping results
for the ﬁve Tunisian Jewish patients are shown in Figure 2,
with the ancestral chromosome at the top. In the Tunisian
Jewish patient no. 5, a deviation from the ancestral chro-
mosome set the new centromeric boundary to D16S3436.
A previously described recombination event in this patient
on the telomeric side12 deﬁned the gene interval in the
Tunisian Jewish patients between the markers D16S3436
and D16S3425. Genotyping of the Palestinian family
with these markers revealed full segregation with the
disease (Figure 3), and lod-score calculations for the marker
D16S3420 yielded amaximum lod score of 4.01 at q¼ 0.00,
thus conﬁrming linkage to this locus. A recombination
event in patient II:1 is evident, but more interesting is
the analysis of individual II-4. For the markers D16S3423,
D16S3437, D16S3436, D16S3424, and D16S3422, this
unaffected family member has inherited two copies of
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gene must be located telomeric to D16S3422 (D16S3432
was not informative in this family). This recombinant
Figure 2. Haplotypes of Chromosome 16q24 in Tunisian Jewish Patients
Top: Ancestral chromosome.
In patient no. 5, deviation from the ancestral chromosome at the markers D16S3425 and D16S3436 on the telomeric and centromeric
sides, respectively, set the disease gene interval to 4 Mb in the Tunisian patients.
Figure 1. Clinical features of BCS
Patients
(A) Corneal opacities due to scars.
(B) Keratoglobus.
(C) Hyperlaxity of the joints.
chromosome, which was passed to
two other unaffected individuals, pa-
tients III-1 and III-6, sets D16S3422
as the centromeric boundary. No re-
combinations were detected in the
Palestinian family on the telomeric
side, but combination of the data
from the Tunisian patients reduced
the disease-gene interval to 2.8 Mb
between the markers D16S3422 and
D16S3425. Not surprisingly, the car-
rier haplotype of the Palestinian pa-
tients was completely different from
that of the Tunisian one.
The candidate interval contained
50 known genes. With the assump-
tion that the BCS gene is expressed
in skin ﬁbroblasts, all 32 genes from
the candidate interval known to be expressed in ﬁbroblasts
were fully sequenced. A homozygous single-base-pair1218 The American Journal of Human Genetics 82, 1217–1222, May 2008
deletion at position 5943 (delA) in ZNF469 was detected in
one of the Tunisian Jewish patients (Figure 4A). The deletion
results in a frameshift and a putative stop codon 16 amino
acids downstream. The sequence variation was conﬁrmed,
then extended to other patients and family members by re-
striction digestions performed on PCR-ampliﬁed DNA with
the use of primer pairs 50-GTGTGCAGGTGACAACTCTC
C-30 and 50-GCGAGGTAAGTGGGTCTTCAC-30. In the pa-
tients, an SmaI site was formed. Two hundred control chro-
mosomes from individuals of Tunisian Jewish origin and
100 control chromosomes from various other ethnic back-
grounds were screened for this deletion, but only the wild-
type allele was found (Figure 4C). In a patient from the
Palestinian family, we detected a single-base-pair deletion
at position 9527 (delG) (Figure 4B) resulting in a premature
stop codon 22 amino acids downstream. This mutation
was conﬁrmed, then extended to other family members by
visualization of the 1 bp difference on an automated ABI
Prism 3100 Genetic Analyzer (Perkin Elmer, Waltham, MA,
USA) (Figure 4D). Genomic DNA was ampliﬁed with the
ﬂuorescent primers 50-GGATGTACAACGAGCACCTG-30
and 50-TTCTTGGCTTCTCCCTCTTG-30, with conditions
previously described.13 We found full segregation of this
mutation in the family, andwe did not ﬁnd it in 240 control
Figure 3. Palestinian Family Pedigree
and Chromosome 16q24 Haplotypes
Recombination event in D16S3422 in indi-
vidual II:4 sets this marker as the centro-
meric boundary. Allele 4 in D16S3420 in
individual II:1 and allele 7 in D16S3437 in
individual III:1 reflect mutations in these
markers.
chromosomes of Palestinian ancestry.
ZNF469was previously found to be ex-
pressed in a wide variety of tissues, in-
cluding thyroid, bone, heart, mam-
mary gland, lymph node, placenta,
lung, connective, prostate, eye, liver,
uterus and brain tissues. Using RT
PCR (Thermo Scientiﬁc Verso c-DNA
Synthesis Kit) (primer pair no. 19 de-
tailed in Table S1, available online), we
show speciﬁc expression of ZNF469
in mRNA extracted from a normal
human cornea (Figure 5).
ZNF469, also known asKIAA1858, is
composed of two very large exons. The
predicted mRNA spans 13,229 bp and
encodes a protein of 3925 amino acids.
ZNF469 has orthologues in Pan troglo-
dytes (95.7%),Macaca mulatta (90.4%),
Mus musculus (56.5%), Canis familiaris
(56.2%) and Rattus norvegicus (53.7%),
but not in C. elegans and S. cerevisiae,
suggesting a relatively late evolution-
ary development. The protein contains three zinc-ﬁnger
domains (type C2H2) located toward its 30 end. Zinc ﬁngers
(ZNFs) are extremely abundant in eukaryotes and have been
classiﬁed into several groups according to their structure.
Onceconsideredto functionexclusivelyas sequence-speciﬁc
DNA-binding motifs, ZNFs are now known to have
additional activities, such as the recognition of RNAs and
proteins.TheC2H2domainsclassify thisproteinasaclassical
ZNF.13 In addition to their DNA-binding properties, classical
ZNFs have been associated with protein-to-protein interac-
tions, and therefore theymay be found outside the nucleus.
We found that ZNF469 has a 30% homology to the
helical parts of COL1A2 [MIM 120160], COL4A1 [MIM
120130], and COL1A1 [MIM 120150] (Figure 6), all of
which are highly expressed in the cornea. Organized as
orthogonal lamellae with small, homogeneous diameters
and regular packing, collagen ﬁbrils are a major compo-
nent of the normal cornea.14 The transparency and
strength of the cornea require the maintenance of this
structural organization, as well as the precise regulation
of ﬁbril and matrix assembly. ZNF469 could act either as
a nuclear transcription factor or as an extra-nuclear regula-
tory molecule involved in the synthesis and/or organiza-
tion of these collagen ﬁbers.The American Journal of Human Genetics 82, 1217–1222, May 2008 1219
Figure 4. Mutations in ZNF469 Cause
BCS
(A) Sequence chromatogram of a control
subject (top) and a Tunisian patient with
a homozygous deletion of A at position
5943 (bottom).
(B) Sequence chromatogram of a control
subject (top) and a Palestinian patient
with a homozygous deletion of G at posi-
tion 9527 (bottom).
(C) SmaI restriction digests of the Tunisian
Jewish mutation. In the carrier chromo-
some, the 533bp product is cleaved to yield
388 bp and 145 bp fragments. Molecular-
weight marker (M), homozygotes (lanes 1
and 2), heterozygotes (lanes 3 and 4),
and control subjects (lanes 5 and 6).
(D) ABI 3100 assay for the detection of the
Palestinian mutation. The 1bp difference is
evident in homozygotes (1 and 2) com-
pared to controls (5 and 6). Heterozygotes
appear as two peaks (3 and 4).
Mutations in collagen genes and
collagen-associated genes might lead
to various corneal diseases. These
could involve different corneal layers,
result in mild or severe visual impair-
ments, be stationary or progressive,
and can affect corneal shape. For ex-
ample, signiﬁcant corneal thinning
has been documented in both classic
Ehlers-Danlos syndrome (EDS) type I
[MIM 130000] and type II [MIM
130010] patients and in mouse
models with COL5A1 [MIM 120215]
and COL5A2 [MIM 120190] alter-
ations.15 As many as nine clinically distinct dystrophies af-
fecting the middle corneal layer (stroma) result frommuta-
tions in the TGFBI gene, which is involved in collagen
metabolism and arrangement.16 Posterior-corneal-layer
dystrophies, such as Fuchs endothelial [MIM 136800]
and posterior polymorphous [MIM 609140] dystrophies,
are associated with COL8A2 mutations.17,18
Of special interest is autosomal-recessive EDS type VI
[MIM 225400], which is often confused with BCS. This
disease, characterized by rupture of the eye globe, joint
hypermobility, and lax skin, is caused by mutations in
the lysyl hydroxylase gene, located on chromosome
1p36.22. Use of polymorphic markers very close to the
lysyl hydroxylase locus enabled us to rule out this gene
as the cause of the disease in the Palestinian family (data
not shown), clearly differentiating BCS from EDS VI.
Figure 5. ZNF469-Expression Studies
The 559bp RT-PCR product in cornea (c), sclera (s), skin fibroblasts
(f) and striated muscle (m). M denotes molecular-weight marker.1220 The American Journal of Human Genetics 82, 1217–1222, May 2008
Figure 6. Partial Homology of ZNF469
to COL1A1
The Smith-Waterman algorithm was used to
calculate local alignment (EMBOSS).
Top line: ZNF469.Interestingly, a thin andbulging cornea is amajor ﬁnding
in keratoconus [MIM148300]. The inheritance of keratoco-
nus is heterogeneous and complex, but in many families it
runs as an autosomal-dominant trait.19 Tyynismaa et al.20
assigned a keratoconus locus to chromosome 16q22.3–
q23.1, close to the location ofZNF469, in a panel of Finnish
families. It is conceivable that some keratoconus patients
could harbor mutations in ZNF469.
BCS shares a number of common clinical features with
osteogenesis imperfecta (OI [MIM 166200]), including
thin cornea and blue sclera, conductive-hearing loss, elastic
skin, and dental anomalies. Most but not all OI patients
have mutations in COL1A1 and COL1A2.21 ZNF469 is an
appealing candidate in OI patients with no mutations in
these two genes.
Identiﬁcation of the BCS gene will provide insight into
molecular pathways involved in the development of the
normal cornea and connective tissues and could shed light
on thepathogenesis ofdisorders that implicate theseorgans.
Supplemental Data
One supplemental table is available with this article online at
http://www.ajhg.org/.
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